Polaris Group (TPE: 6550)

Market Cap	35.22B
Revenue (ttm)	75.65M
Net Income (ttm)	-2.25B
Shares Out	746.20M
EPS (ttm)	-3.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	583,905
Open	45.95
Previous Close	45.75
Day's Range	45.95 - 47.50
52-Week Range	43.00 - 78.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 9, 2025

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 165
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6550

Financial Performance

In 2023, Polaris Group's revenue was 7.48 million, an increase of 16.18% compared to the previous year's 6.44 million. Losses were -1.58 billion, 37.1% more than in 2022.